FDA Guidance on Digital Health Technologies

What healthcare companies need to know—straight from a legal lens.
Digital health is no longer the future—it’s the present. From wearable sensors to software that supports clinical trials, Digital Health Technologies (DHTs) are transforming how healthcare is delivered and regulated. The FDA’s latest guidance aims to bring clarity, but for many businesses, it also raises new questions.
As a law firm that works closely with FDA-regulated companies, we’ve put together a breakdown of what this guidance means—and how to stay ahead of it.

Share this article

Keep Reading

Blog, Life Sciences

TCPA Compliance in M&A

A Visual Case Study of Morris v. Lincare, Inc. For.....

Blog, Promotions

Pharma’s Quiet Risk: Your Telehealth Program May Be Illegal

When people think of kickbacks, they imagine envelopes under tables.....

Blog, Life Sciences

Top 5 Life Sciences Regulatory & Policy Updates

This newsletter summarizes the top five recent regulatory updates and.....

Unlock This Content

🔗 Link copied!